PCN108 Cost-Effectiveness of Axicabtagene Ciloleucel (AXI-CEL) and Tisagenlecleucel (TISA-CEL) in Adult Patients with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) in Canada.
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.200
https://www.valueinhealthjournal.com/article/S1098-3015(21)00417-4/fulltext
Section Title :
Section Order :
10772
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00417-4&doi=10.1016/j.jval.2021.04.200